Variational AI will be at #BIO2026, San Diego, June 22-25.
Scoping an early-stage program where #GenerativeAI could speed up multi-property optimization? Let's talk!
Book a meeting using the platform or via email at [email protected]
https://t.co/uvjhQgVXkj
#AIDD#GenAIinPharma
@VariationalAI is hiring a Chemical Data Scientist! Curate datasets across potency, ADMET, gene expression, etc.... Build featurizations that feed Enki™. Vancouver or remote in Canada. https://t.co/TNlqrnMxty #AIDD#Hiring#Cheminformatics#DataScience
@VariationalAI and 3C Therapeutics are launching a research collaboration to design next-generation Degrader Antibody Conjugates (DACs), with support from Innovate BC's Integrated Marketplace program.
Full release 👉
https://t.co/6VowrtDX6q
"The new unit economics of drug discovery" at #WebSummit yesterday: Handol Kim, Ricardo Baptista Leite (HealthAI), and Jennifer Strong (SHIFT Podcast) on how AI shifts pharma from massive libraries to targeted molecular design, and what regulators need to do next. #AIDD
At #WebSummit Vancouver this week? Find us at Booth G1-09 today only to talk about our generative AI platform for early-stage small molecule discovery. #GenerativeAI#AIDD
Today at Boston PBSS, our CTO Jason Rolfe is speaking about generative molecular design, and specifically how starting from better chemical space leads to better leads with fewer DMTA cycles. How it works? https://t.co/ooVUmRXrVD
#AIDD#DrugDiscovery#PBSS
Most #DrugDiscovery programs optimize within known chemical space. What happens when you can explore beyond it? Jason Rolfe makes the case at #PBSS Cambridge, on April 28. 👉 Interested? Register here: https://t.co/XwaUfszX1T
#AIDD#GenerativeAI
Today at ALL IN Talks West, Variational AI CEO Handol Kim speaks on closing the gap between #AI research and real-world impact, using #DrugDiscovery as the proving ground.
🔗 https://t.co/m9nvbjvCOj
#GenerativeAI#AIDD
We just released Enki™ 4 🚀
760 pre-trained targets, 12+ target classes, and new coverage for degraders, PROTACs, and ADC payloads. Our Goal? Eliminating hit ID and hit-to-lead! https://t.co/M02youUE1U
#Enki4#AIDD#GenerativeAI#VariationalAI#GenAIinPharma#DrugDiscovery